深度学习影像组学列线图预测软组织肉瘤复发:多中心研究
本研究在三个独立中心回顾性纳入282例接受MRI及手术切除的软组织肉瘤患者,构建基于平扫及增强MRI的深度学习影像组学列线图(DLRN)预测术后复发。两个DLRN模型在开发集和外部测试集中均表现出较好的预后预测能力(C指数≥0.721,中位AUC≥0.746),并可将复发风险分为低、中、高三层。
要点
- 基于平扫MRI的DLRN1和基于平扫+增强MRI的DLRN2均可预测STS术后复发。
- DLRN模型的预测效能优于分期系统和Ki67等常用预测指标。
- DLRN将复发风险分为低、中、高三层,有助于术后分层管理。
核心结论
- DLRN模型是预测软组织肉瘤术后复发的可靠且经外部验证的工具。
- DLRN模型预测效能优于分期系统、Ki67及其他模型,决策曲线显示临床获益更大。
- DLRN模型可将STS复发风险分为低、中、高三层,便于针对性术后管理。
研究设计与样本
- 回顾性多中心研究,纳入三个独立中心共282例接受MRI检查和手术切除的STS患者。
- 282例中113例接受了额外的增强MRI扫描。
- 开发队列来自一个中心,外部测试队列来自另外两个中心。
- 构建了两个基于MRI的DLRN模型:DLRN1整合平扫MRI影像组学特征与临床数据,DLRN2整合平扫及增强MRI影像组学特征与临床预测因子。
- 参考标准为肿瘤复发,比较对象包括分期系统、Ki67及其他预测模型。
诊断标准与关键数值
- DLRN1和DLRN2在开发集和外部测试集中C指数≥0.721,中位AUC≥0.746。
- 与大多数其他模型和预测因子比较P值<0.05。
- 整合Brier评分≤0.159。
- 选择适当cutoff值将STS复发分为低、中、高风险三层。
临床应用与阅片要点
- 术前MRI可用于构建DLRN预测STS术后复发风险,辅助制定更积极的治疗决策。
- DLRN风险分层可用于术后靶向管理,高风险层可能需要更密切随访。
- DLRN预测效能优于传统分期系统和Ki67,阅片时可结合影像组学特征综合评估。
局限性
- 回顾性研究设计。
- 仅113例(282例中)接受增强MRI,DLRN2的增强序列数据并非全部患者具备。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the performance of a deep learning radiomic nomogram (DLRN) model at predicting tumor relapse in patients with soft tissue sarcomas (STS) who underwent surgical resection.
METHODS: In total, 282 patients who underwent MRI and resection for STS at three independent centers were retrospectively enrolled. In addition, 113 of the 282 patients received additional contrast-enhanced MRI scans. We separated the participants into a development cohort and an external test cohort. The development cohort consisted of patients from one center and the external test cohort consisted of patients from two other centers. Two MRI-based DLRNs for prediction of tumor relapse after resection of STS were established. We universally tested the DLRNs and compared them with other prediction models constructed by using widespread adopted predictors (i.e., staging systems and Ki67) instead of radiomics features.
RESULTS: The DLRN1 model incorporated plain MRI-based radiomics signature into the clinical data, and the DLRN2 model integrated radiomics signature extracted from plain and contrast-enhanced MRI with the clinical predictors. Across both study sets, the two MRI-based DLRNs had relatively better prognostic capability (C index ≥ 0.721 and median AUC ≥ 0.746; p < 0.05 compared with most other models and predictors) and less opportunity for prediction error (integrated Brier score ≤ 0.159). The decision curve analysis indicates that the DLRNs have greater benefits than staging systems, Ki67, and other models. We selected appropriate cutoff values for the DLRNs to divide STS recurrence into three risk strata (low, medium, and high) and calculated those groups' cumulative risk rates.
CONCLUSION: The DLRNs were shown to be a reliable and externally validated tool for predicting STS recurrence by comparing with other prediction models.
KEY POINTS: • The prediction of a high recurrence rate of STS before emergence of local recurrence can help to determine whether more active treatment should be implemented. • Two MRI-based DLRNs for prediction of tumor relapse were shown to be a reliable and externally validated tool for predicting STS recurrence. • We used the DLRNs to divide STS recurrence into three risk strata (low, medium, and high) to facilitate more targeted postoperative management in the clinic.
引用
- Liu S, Sun W, Yang S, et al. Deep learning radiomic nomogram to predict recurrence in soft tissue sarcoma: a multi-institutional study. Eur Radiol. 2021. PMID: 34448928. doi:10.1007/s00330-021-08221-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。